Vertex Pharmaceuticals
VRTX
#203
Rank
A$152.64 B
Marketcap
A$600.11
Share price
1.40%
Change (1 day)
-22.48%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): A$7.09 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$12.00 Billion. , an increase over its 2024 earnings that were of A$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 A$6.50 B1568.4%
2024 A$0.38 B-93.69%
2023 A$6.17 B3.19%
2022 A$5.98 B53.56%
2021 A$3.89 B-12.06%
2020 A$4.43 B118.45%
2019 A$2.02 B120.64%
2018 A$0.91 B1473.64%
2017 A$58.44 M197.6%
2016 A$19.63 M-102.97%
2015 -A$0.67 Billion-28.46%
2014 -A$0.93 Billion-51.5%
2013 -A$1.91 Billion-30584.68%
2012 A$6.25 M-95.47%
2011 A$0.13 B
2009 -A$0.83 Billion
2007 -A$0.58 Billion83.1%
2006 -A$0.32 Billion59.02%
2005 -A$0.2 Billion3.28%
2004 -A$0.2 Billion-38.16%
2003 -A$0.31 Billion
2000 -A$53.12 Million-20.38%
1999 -A$66.71 Million31.62%
1998 -A$50.68 Million91.05%
1997 -A$26.53 Million-36.24%
1996 -A$41.61 Million12.45%
1995 -A$37 Million27.4%
1994 -A$29.04 Million-1833.33%
1993 A$1.67 M-112.12%
1992 -A$13.83 Million175%
1991 -A$5.03 Million-12.2%
1990 -A$5.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.84 B 620.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$9.21 B 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.67 B 110.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$31.30 B 381.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.02 B 100.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-A$0.11 Billion-101.63%๐Ÿ‡บ๐Ÿ‡ธ USA